The letter highlights HHS’s May 28, 2025, cancellation of a $766 million contract with Moderna for developing vaccines against future pandemic influenza strains, including bird flu.

In experiments conducted in a biosafety level 3 facility, the researchers studied ferrets that had antibodies to seasonal flu ...

US Health Secretary Robert F. Kennedy Jr.’s vaccine policies and commentary largely appear to contradict his pledge to revamp ...

Novavax reports strong immune responses from H5N1 avian flu vaccine candidate, showing promise in single and two-dose ...

HPAI is more than an animal health crisis: it is a global emergency destabilizing agriculture, food security, trade and ...

Studies suggest that people who had seasonal flus or vaccinations have low antibody levels against H5N1 bird flu.

Bacteriologist and parasitologist Michelle Jakaitis uses a microscope to view a training sample of veligers, which are the ...

The HHS is betting $500 million on developing a universal flu vaccine that could protect against multiple flu strains.

A study spearheaded by researchers at Stanford Medicine reports a substantial increase in cases of acute necrotizing ...

Novavax, Inc. (NVAX) on Thursday announced preclinical data demonstrating that the company’s H5N1 bird flu vaccine candidate ...

Dairies say the USDA relief money helped them sustain operations as bird flu decimated milk production, but critics say the ...

Cambodia's health ministry today announced another H5N1 avian flu infection, the country's 14th of the year. Meanwhile, ...